APA (7th ed.) Citation

Hsieh, H., Urak, R., Clark, M. C., Kwak, L. W., Forman, S. J., & Wang, X. Capivasertib enhances chimeric antigen receptor T cell activity in preclinical models of B cell lymphoma. Elsevier.

Chicago Style (17th ed.) Citation

Hsieh, Hui-Ju, Ryan Urak, Mary C. Clark, Larry W. Kwak, Stephen J. Forman, and Xiuli Wang. Capivasertib Enhances Chimeric Antigen Receptor T cell Activity in Preclinical Models of B Cell Lymphoma. Elsevier.

MLA (9th ed.) Citation

Hsieh, Hui-Ju, et al. Capivasertib Enhances Chimeric Antigen Receptor T cell Activity in Preclinical Models of B Cell Lymphoma. Elsevier.